OHI, US6819361006

UBS cuts Omega Healthcare Investors stock target to USD 52.00

Published on 10/17/2026 at 22:35 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

Omega's next results are scheduled for November 4, 2026. Omega Healthcare Investors stock was last quoted at EUR 40.77 on October 16, 2026 at 11:00 p.m. CEST.

Analyst view and trading dates

UBS Group lowered its Omega Healthcare Investors target from USD 54.00 to USD 52.00 on October 13, 2026.
Omega Healthcare Investors is scheduled to release third-quarter results on November 4, 2026.
Omega Healthcare Investors stock was last quoted at EUR 40.77 at Lang & Schwarz on October 16, 2026 at 11:00 p.m. CEST.
Omega Healthcare Investors had a P/E ratio of 16.30 and a dividend yield of 6.00 percent on October 16, 2026.

OHI, US6819361006, Illustration mit AI erstellt.

MarketBeat reported on October 13, 2026 that UBS Group lowered its price target for Omega Healthcare Investors (ISIN US6819361006) from USD 54.00 to USD 52.00 while maintaining a Buy rating. Against the USD 45.64 home-market price, the new target stood 13.94 percent higher. Omega Healthcare Investors was last quoted at EUR 40.77 at Lang & Schwarz on October 16, 2026 at 11:00 p.m. CEST.

Results date is November 4

Omega Healthcare Investors has scheduled its third-quarter 2026 earnings conference call for November 4, 2026, at 10:00 a.m. ET, according to its investor-relations page. The company identifies the event as its next earnings call, giving the market a defined date for the next fundamental update.

Range keeps the stock below its high

On October 16, 2026, the NYSE quote stood at USD 45.64, up 0.24 percent from the prior close of USD 45.53. Trading volume was 1,232,559 shares against an average volume of 1,926,650. The 52-week range was USD 39.26 to USD 52.39, leaving the stock 12.89 percent below its high and 16.25 percent above its low.

Valuation and income remain central

Omega Healthcare Investors had a market capitalization of USD 13.8 billion, a P/E ratio of 16.30 and a dividend yield of 6.00 percent on October 16, 2026. MarketBeat reported that second-quarter revenue reached USD 328.25 million, up 16.20 percent year over year, while quarterly earnings per share came to USD 1.19 against a USD 0.51 consensus estimate.

Comparison with peers

Omega Healthcare Investors (NYSE, USD): P/E 16.30, market capitalization USD 13.8 billion
National Health Investors (NYSE, USD): up 0.93 percent, P/E 19.16, market capitalization USD 3.3 billion
Healthpeak Properties (NYSE, USD): up 0.11 percent, P/E 54.23, market capitalization USD 13.1 billion

Trading context for investors

Omega's portfolio centers on skilled nursing and assisted-living properties leased to healthcare operators. Its investor-relations page lists 1,108 properties and 100,588 beds as of June 30, 2026, which gives the November earnings date particular weight for assessing occupancy, tenant performance and cash generation.

Omega Healthcare Investors was last quoted at EUR 40.77 at Lang & Schwarz on October 16, 2026 at 11:00 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of Omega Healthcare Investors stock.